[Potential of PET in the diagnosis and the assessment of treatment effectiveness in progressive malignant glioma]
- PMID: 21882605
[Potential of PET in the diagnosis and the assessment of treatment effectiveness in progressive malignant glioma]
Abstract
Examination including MRI (CT), PET with sodium 11C-butyrate (11C-SB) and 18fluorodeoxyglucose (18F-FDG) was carried out in 59 patients with continuing growth of malignant glioma. It was established that 11C-SB-PET is characterized by high sensitivity (94.1%) in detecting continuing growth as well as to differentiating it from necrosis. Our data were instrumental in prognosis and assaying metabolic levels in tumor (T/NT ratios) which are regarded as indices of accumulation (IA) of 18F-FDG-PET (FDG-IA) prior to conservative treatment. There were a direct correlation between metabolic activity of neoplasms and an inverse one with FDG-IA (r=-0.24).
Similar articles
-
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.J Neurol Sci. 2006 Jul 15;246(1-2):85-94. doi: 10.1016/j.jns.2006.02.015. Epub 2006 Mar 6. J Neurol Sci. 2006. PMID: 16603193
-
11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.J Neurosurg. 2019 Sep 21;131(3):676-686. doi: 10.3171/2018.4.JNS1859. Print 2019 Sep 1. J Neurosurg. 2019. PMID: 30239314
-
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):52-9. doi: 10.1007/s00259-004-1598-6. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15309332
-
Clinical applications of PET in brain tumors.J Nucl Med. 2007 Sep;48(9):1468-81. doi: 10.2967/jnumed.106.037689. Epub 2007 Aug 17. J Nucl Med. 2007. PMID: 17704239 Review.
-
Positron emission tomography for radiation treatment planning.Strahlenther Onkol. 2005 Aug;181(8):483-99. doi: 10.1007/s00066-005-1422-7. Strahlenther Onkol. 2005. PMID: 16044216 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials